Guardant Health
GH
#2739
Rank
HK$37.71 B
Marketcap
HK$305.55
Share price
-2.12%
Change (1 day)
105.75%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -HK$3.4 Billion

According to Guardant Health 's latest financial reports the company's current earnings are HK$0.73 Billion. , an increase over its 2023 earnings that were of -HK$3.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -HK$3.39 Billion-9.12%
2023 -HK$3.73 Billion-26.73%
2022 -HK$5.08 Billion69.96%
2021 -HK$2.99 Billion56.35%
2020 -HK$1.92 Billion252.69%
2019 -HK$0.55 Billion-17.22%
2018 -HK$0.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$1.66 Billion-51.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$3.92 Billion 15.93%๐Ÿ‡บ๐Ÿ‡ธ USA